Study of MDX2301 for healthy adults and those at higher risk for severe COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests an investigational drug called MDX2301 to see if it's safe in healthy adults and in adults who are at higher risk for severe COVID-19. Higher risk means you have conditions like asthma, diabetes, heart disease, or other listed health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 64 years old
- Be either in good health OR have one or more of the listed risk factors for severe COVID-19 (like asthma, diabetes, heart disease, etc.)
- Not have received a COVID-19 vaccine or any COVID-19 treatment before joining
- Not be pregnant, breastfeeding, or planning to become pregnant during the study
- Be willing to use effective birth control if of childbearing potential
- Be able to visit the clinic as scheduled and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an oral medication (mitoquinone/mitoquinol) taken after a high-risk COVID-19 exposure can help prevent you from becoming sick. It is designed for people who currently have no symptoms but had a significant exposure to someone with confirmed COVID-19.
This trial tests a new drug called B10-FC in two groups: healthy volunteers and people recently diagnosed with mild-to-moderate COVID-19. It aims to check the drug's safety, how the body processes it, and how the immune system responds. The results will help decide if the drug should be studied further.
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.
This study tests a new inhaled drug (MKND-201) in healthy volunteers to see if it's safe and how the body processes it. If you are a generally healthy adult between 40 and 65, you might be able to help researchers understand if this medicine is safe for future studies.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.